- Home
- TAK vs XYL Comparison
TAK vs XYL Comparison
Compare TAK & XYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAK | XYL |
|---|---|---|
| Founded | 1781 | 2011 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3B | 36.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TAK | XYL |
|---|---|---|
| Price | $14.53 | $137.11 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $161.33 |
| AVG Volume (30 Days) | ★ 2.6M | 1.5M |
| Earning Date | 01-29-2026 | 02-03-2026 |
| Dividend Yield | ★ 3.68% | 1.17% |
| EPS Growth | N/A | ★ 13.52 |
| EPS | 0.14 | ★ 3.88 |
| Revenue | ★ $29,846,840,032.00 | $8,894,000,000.00 |
| Revenue This Year | N/A | $6.53 |
| Revenue Next Year | $0.59 | $3.71 |
| P/E Ratio | $102.85 | ★ $35.34 |
| Revenue Growth | N/A | ★ 5.58 |
| 52 Week Low | $12.80 | $100.48 |
| 52 Week High | $15.69 | $154.27 |
Technical Indicators
Market Signals| Indicator | TAK | XYL |
|---|---|---|
| Relative Strength Index (RSI) | 58.96 | 38.05 |
| Support Level | $14.20 | $136.46 |
| Resistance Level | $14.53 | $140.73 |
| Average True Range (ATR) | 0.13 | 2.21 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 73.00 | 9.81 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About XYL Xylem Inc. New
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.